Works matching IS 03065251 AND DT 2005 AND VI 59 AND IP 3
1
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 371, doi. 10.1111/j.1365-2125.2004.02199.x
- Mahé, I.;
- Bertrand, N.;
- Drouet, L.;
- Simoneau, G.;
- Mazoyer, E.;
- dit Sollier, C. Bal;
- Caulin, C.;
- Bergmann, J. F.
- Article
2
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 365, doi. 10.1111/j.1365-2125.2005.02229.x
- Owen, Andrew;
- Goldring, Chris;
- Morgan, Paul;
- Chadwick, David;
- Park, B. Kevin;
- Pirmohamed, Munir
- Article
3
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 310, doi. 10.1111/j.1365-2125.2004.02233.x
- van Kan, H. J. M.;
- Groeneveld, G. J.;
- Kalmijn, S.;
- Spieksma, M.;
- van den Berg, L. H.;
- Guchelaar, H. J.
- Article
4
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 271, doi. 10.1111/j.1365-2125.2004.02235.x
- Atcheson, Bronwyn A.;
- Taylor, Paul J.;
- Mudge, David W.;
- Johnson, David W.;
- Hawley, Carmel M.;
- Campbell, Scott B.;
- Isbel, Nicole M.;
- Pillans, Peter I.;
- Tett, Susan E.
- Article
5
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 291, doi. 10.1111/j.1365-2125.2004.02251.x
- Hui, C. K.;
- Cheung, B. M. Y.;
- Lau, G. K. K.
- Article
6
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 281, doi. 10.1111/j.1365-2125.2004.02253.x
- Green, B.;
- Greenwood, M.;
- Saltissi, D.;
- Westhuyzen, J.;
- Kluver, L.;
- Rowell, J.;
- Atherton, J.
- Article
7
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 335, doi. 10.1111/j.1365-2125.2005.02254.x
- Csajka, C.;
- Haller, C. A.;
- Benowitz, N. L.;
- Verotta, D.
- Article
9
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 298, doi. 10.1111/j.1365-2125.2004.02257.x
- Hombhanje, F. W.;
- Hwaihwanje, I.;
- Tsukahara, T.;
- Saruwatari, J.;
- Nakagawa, M.;
- Osawa, H.;
- Paniu, M. M.;
- Takahashi, N.;
- Lum, J. K.;
- Aumora, B.;
- Masta, A.;
- Sapuri, M.;
- Kobayakawa, T.;
- Kaneko, A.;
- Ishizaki, T.
- Article
10
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 314, doi. 10.1111/j.1365-2125.2004.02319.x
- Nath, Christa E.;
- Shaw, Peter J.;
- Montgomery, Kay;
- Earl, John W.
- Article
11
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 325, doi. 10.1111/j.1365-2125.2004.02325.x
- de Jonge, Milly E.;
- Huitema, Alwin DR.;
- Schellens, Jan HM.;
- Rodenhuis, Sjoerd;
- Beijnen, Jos H.
- Article
12
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 302, doi. 10.1111/j.1365-2125.2004.02329.x
- Saito, Masato;
- Yasui-Furukori, Norio;
- Uno, Tsukasa;
- Takahata, Takenori;
- Sugawara, Kazunobu;
- Munakata, Akihiro;
- Tateishi, Tomonori
- Article
13
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 265, doi. 10.1111/j.1365-2125.2004.02334.x
- Greig, Lynn D.;
- Leslie, Stephen J.;
- Gibb, Fraser W.;
- Tan, Sherilyn;
- Newby, David E.;
- Webb, David J.
- Article
14
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 355, doi. 10.1111/j.1365-2125.2005.02335.x
- Valle, Marta;
- di Salle, Enrico;
- Jannuzzo, Maria Gabriella;
- Poggesi, Italo;
- Rocchetti, Maurizio;
- Spinelli, Riccardo;
- Verotta, Davide
- Article
15
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 3, p. 346, doi. 10.1111/j.1365-2125.2005.02348.x
- Chaikin, P.;
- Gillen, M. S.;
- Malik, M.;
- Pentikis, H.;
- Rhodes, G. R.;
- Roberts, D. J.
- Article